Sign in

CIK 0001919246

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
863335449
Phone
+1 919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$44,939
in 3 filings, $45K under 10b5-1 plans

Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-07-02 Plesha Scott M. CEO and President Grant or award +83,678 83,678
2025-07-02 Plesha Scott M. CEO and President Grant or award · Restricted Stock Units +83,678 83,678
2025-07-02 Plesha Scott M. CEO and President Grant or award · Stock Option +255,000 255,000

Page 1 of 1 · 3 trades